Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Impact of A Survivorship Care Plan and Embedded Navigation Tool (ASCENT) in Patients With Prostate Cancer Undergoing Curative-Intent Radiotherapy With Concurrent Androgen Deprivation Therapy (ADT)

NCT03424837 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT03424837
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03424837 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Impact of A Survivorship Care Plan and Embedded Navigation Tool (ASCENT) in Patients With Prostate Cancer Undergoing Curative-Intent Radiotherapy With Concurrent Androgen Deprivation Therapy (ADT)
Lead sponsor
Duke University
Phase
Not applicable
Overall status
Completed
Start date
January 11, 2019
Completion date
November 24, 2020
Enrollment
77 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer